Madrigal Pharmaceuticals Inc (MDGL)
Revenue
$1.43B
TTM · Period ending: · USD
MDGL Revenue
Latest reported$1.43Bperiod ending
Latest reported$1.43Bperiod ending
MDGL TTM Revenue ($0.00 → $1.43B)
TTM revenue
High-resolution chart · PNG
MDGL revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 1,427,940,000 | |
| 1,283,940,000 | |
| 1,132,490,000 | |
| 958,403,000 | |
| 740,640,000 | |
| 515,547,000 | |
| 317,383,000 | |
| 180,133,000 | |
| 76,813,000 | |
| 14,638,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,437,000 | |
| 7,437,000 | |
| 7,437,000 | |
| 7,584,000 | |
| 3,570,000 | |
| 5,234,000 | |
| 6,588,000 | |
| 7,584,000 | |
| 8,198,000 | |
| 9,917,000 | |
| 11,923,000 | |
| 14,803,000 | |
| 15,446,000 | |
| 142,468,000 | |
| 143,758,000 | |
| 144,245,000 | |
| 140,201,000 | |
| 11,068,000 | |
| 7,756,000 | |
| 4,584,000 | |
| 4,691,000 | |
| 3,419,000 | |
| 2,081,000 | |
| 743,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 173,000 |